Sittner & Nelson’s Idexx Laboratories IDXX Stock Holding History

Sittner & Nelson’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1	Closed	-$536	–	495
2025 Q2	$536	Hold	1	–	–	﹤0.01%	492
2025 Q1	$420	Hold	1	–	–	﹤0.01%	483
2024 Q4	$413	Buy	+1	New	+$439	﹤0.01%	471

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Sittner & Nelson's IDXX Position: Q3 2025 in Review

Sittner & Nelson sold out of Idexx Laboratories (IDXX) in Q3 2025, closing a stake of 1 share — an estimated $536 sold.

Sittner & Nelson first reported a position in IDXX in Q4 2024 and held it in 3 quarters. The position peaked at $536 in Q2 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q3 2025.

Sittner & Nelson reported no remaining Idexx Laboratories position as of Q3 2025 after selling out during the quarter.
Sittner & Nelson sold 1 Idexx Laboratories share in Q3 2025, an estimated $536.
Sittner & Nelson first reported a position in Idexx Laboratories in Q4 2024 and held it in 3 quarters.
Sittner & Nelson's Idexx Laboratories position peaked at $536 in Q2 2025.
1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2025.

Based on Sittner & Nelson's 13F filing for Q3 2025, filed 14 Nov 2025.